|
|
 |
ADF TecnoGen is the largest specialised center in Spain and the most experienced private paternity testing laboratory. We invest in the most accurate technology and advanced equipments to provide reliable genetic testing with a differenciated level of service. |
|
|
 |
Agrenvec is a spin off company from the National Agriculture Research Institute focused on the R&D and marketing of biotechnological processes and tools to produce any protein of interest in plants trough the use of viral vectors. |
|
|
|
|
|
Algenex is a company based on biotechnology developments in the field of diagnosis, vaccines, adjuvants and therapeutic molecules. The company is proprietary of recombinant products and a unique technology to produce them based on insect larvae combined with recombinant baculovirus vectors. |
|
|
|
Amplicel Soluciones Diagnosticas is a company from the Parque científico de Madrid who main activity is molecular diagnostic, in the field of microbiological and hereditary and metabolic diseases. Amplicel also colaborates with other research groups for the designing and realization of research projects. Amplicel uses the most advanced techniques of molecular biology, mainly, the real-time polymerase chain reaction (PCR), to detect and quantify nucleic acids, to study genic expression and to determine single nucleotide polymorphisms (SNPs). |
|
|
|
|
|
Applied Molecular Development is focused on the development of new molecules to be used in the diagnosis and treatment of asthma and human allergies. It is involved in human genomics projects, searching genes related to asthma and allergies to be used in new drugs. It is also modifying, through genetic engineering, allergens and antibodies capable of recognizing these allergens. |
|
|
|
Bioalma develops technology to provide innovative solutions to specialized bioinformatics problems. They provide services in the areas of DNA microarrays, automated information extraction, protein structure prediction and genomics. |
|
|
|
|
|
BIOAQUA is a young, Spanish company, incorporated in 2001, whose main activities are focused towards research, development and supply of raw materials and new ingredients from marine origin. Actions done by BIOAQUA are base on the principle of sustainable use of marine natural resources. |
|
|
|
BIOMOL-INFORMATICS SL offers consulting services on Bioinformatics in areas of research, diagnostics and pharmaceutical industry. We are specialist in in silico analysis and prediction of new drugs activity on 3D models of proteins and in molecular dynamics techniques applied to docking of compounds. BIOMOL-INFORMATICS is a spin-off company of Parque Científico de Madrid, located in the campus of Autonomous University.
|
|
|
|
|
|
Bionostra is a biotechnology company which offers products and services to academic centres and companies in two main areas of activity: Recombinants Production and GeneticIdentification. |
|
|
|
Biotools, B & M Labs is focused on the application of molecular biology techniques for the resolution of problems in the areas of agrifood, biomedical and veterinary sciencies, offering a complete solution platform for PCR and molecular biology R&D. Biotools is leader in real time kits platform based on its patented Lionprobes technology. |
|
|
|
|
|
Biotherapix is the company from Genetrix Group specialized in human antibodies and related molecules. Its activity is focused on the generation of novel therapeutic molecules based on antibodies for the treatment of infectious, degenerative and inflammatory diseases. Biotherapix’ therapeutic platforms make it a competitive company in the development of therapeutic molecules of human origin. |
|
|
|
Biotecnologías Aplicadas (BTSA) is the first european company manufacturing natural Vitamin E and natural antioxidant using their own technology for the agro industry, dietetics and cosmetic industry. |
| |
|
|
|
|
Cellerix, a subsidiary from Genetrix Group, is actively developing and producing innovative medicines based on the use of stem cells of adult origin. The company is engaged in clinical trials for the treatment of fistulas and skin regeneration. Cellerix was the first company in Europe to obtain Orphan Drug Designation for a cellular product. |
|
|
|
CircaGen is specialised in cytogenetic and molecular diagnostic, covering current molecular biological techniques to identify the underlying molecular defects in inherited disease. |
|
|
|
|
|
|
|
Decantum Systems S.L gives solutions to actual problems in Agroalimentary Quality Laboratories. These consist on fast process to detect veterinary residues, contaminants and drugs in biological matrix with very low cost and almost any machines. The analysis times are for 10 min (simple matrix) to 60 min (complex matrix). We can develop analysis for Alimentary Alarm in less than 20 days. Vitaltech Ibérica S.L commercializes the analysis in kits for 20 samples.
|
|
|
|
|
|
Exxentia is the leading European company in biotechnology devoted to the extraction of active principles from plants. We develop and manufacture natural plant extracts, which we distribute to the pharmaceutical, dietetic, nutritional and cosmetic industries in over 20 countries.
We are pioneers in applying the regulatory and technical aspects required by the health authorities to market natural products. Thus, Exxentia is the best partner for companies that require a professional supplier of high quality extracts. Moreover, we are experts in formulation and development of products based on naturals extracts.
Exxentia offers an extensive range of the best plant-based extracts in different forms:
- Dry Extracts
- Fluid Extracts
- Glycerinated Extracts
- Soft Extracts
|
|
|
|
FINA BIOTECH is a subsidary of LABORATORIOS INDAS. Our company has financed I+D projects since 2002, in these main areas of interest:
- Cell therapy with adult stem cells
- Cancer diagnosis/ prognosis markers
- Cardiovascular disease markers
- Alzheimer’s Disease markers
- Fertility
FINA BIOTECH searches I+D projects to finance and companies interested in licensing the products developed.
|
|
|
|
|
|
Genetrix is a leading bio-pharmaceutical corporation in the field of regenerative and molecular medicine. |
|
|
|
|
|
|
|
Halotech DNA, SL is a small company created in February 2008. Its stakeholders are Chromacell and Suan Biotech FCR, Private Equity Fund managed by Suanfarma Biotech SGECR.
Halotech activities are R&D, production and distribution related to analysis of fragmented DNA in semen samples (human and animal) and bacteria. It also has products under development to visualize different parameters in fragmented DNA.
The R&D and production activities take part at Parque Científico de Madrid. Management and commercial activities are located at Suanfarma Biotech SGECR Offices. |
|
|
|
The Institute of Applied Reseach (IAR) of Hispanagar, develops and commercialises Activated Agarose Beads for biomolecules purification (Chelates) through Affinity chromatography techniques and enzymes immobilization (Gliyoxal and Aminoethyl supports)
The IAR is supported by the experience of Hispanagar, a company leader in the biotechnology market for more than 60 years.
The innovation and reseach spirit of the IAR, allows the Institute to show the widest product market range with different metals (Ni. Co, Cu, Zn,) and different agarose percentages. The Chelated Products are presented on different formats: bulk, packed columns and spin columns, offering the customer first the possibility of a primary screening with our test kits to choose the most suitable resin (also available for the immobilization supports).
These products, are supported by the IAR continuous advice, the own raw materials from seaweed derivates and strict quality controls, being the Activated Agarose Beads the product with the most added value of Hispanagar. |
|
|
|
|
|
IMBIOSIS is a company that belongs to the Biotech group Genetrix and is specialized in the application of biotechnology in food analysis.
As a National Biotechnology Centre spin-off (Spanish Council for Scientific Research, “CSIC”), we work under the basis of a technology transfer procedure. This technology has been developed by the Gluten Unit, a research group that is pioneer in gluten analysis.
IMBIOSIS is the only company on the market capable of offering each one of the technical analyses available for gluten detection, from raw materials to transformed ones and additives. Amongst these techniques, the ELISA-R5 has been adopted as the official method by the Codex Alimentarius, an international organism that belongs to the FAO and OMS.
Additionally, we are the sole providers of the “Cocktail” solution, special for gluten extraction from heat processed foods previous to the analysis.
|
|
|
|
Inagrosa is specialised in obtaining 20-L fundamental amino acids using their own, original process, through which are obtained oligopeptides and biologically active and stable amino acids that penetrate the nucleus of cells to act as extra-cellular transcription factors and with a wide spectrum of applications ranging from industrial microbiology (fermentation) to medicine, especially in the central nervous system, and including agriculture, dietetics and cosmetics. |
|
|
|
|
|
Ingenasa focuses its activities on the R&D and marketing of new products for the diagnosis and prevention of in the areas of Animal Health and Agriculture. Ingenasa have already developed a large catalogue of diagnostic kits for very important infectious diseases. |
|
|
|
Integromics offers initiatives and solutions in the field of Information Technologies for Life Sciences with particular focus on Genomics and Proteomics. |
|
|
|
|
|
JUSTE, S.A.Q.F. is a company which researches, develops and distributes pharmaceutical products. Its main business areas are the distribution and commercialization of drugs (both for hospital and prescription use) and contrast media agents. JUSTE also has an outstanding R+D and industrial activity related to the generation and manufacture of soft-gel capsules.
JUSTE is aware of the advances in biotechnology and considers very important the use of the genetics for a personalized medicine. JUSTE commits itself in the innovative biotechnology industry with new products for clinical diagnosis.
JUSTE, through Juste International subsidiaries, is present in Central America, as well as in Argentina, Mexico and Brazil via Justesa Imagen affiliates. |
|
|
|
Kytos is a Cell technology company developing products and services based on its uniquely selected human cell lines. They have developed an encapsulated cell technology to deliver continuous and local disease-altering therapy for Parkinson’s disease patients.
|
|
|
|
|
|
|
|
Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and future shaped by 35,214 employees in 63 countries. Merck’s operating activities come under the umbrella of Merck KGaA, in wich the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck&Co. was expropiated and has been an independent company ever since.
|
|
|
|
|
|
|
Spin out company that develops novel technologies for use in diagnostics and therapy based on the expression of antibodies and antibody-like molecules in bacteria. The company has 3 patent applications covering these technological platforms. In addition, it has created tools for the efficient selection and display of antibodies and antibody-like molecules in bacteria.
|
|
|
|
Normon is a Pharmaceutical Company, which leads the generics market in Spain. This is possible thanks to its experience in galenical and clinical research. Normon also developed joint plans in the fields of Enzimology, Microbiology and Immunology with important Spanish institutions. Nowadays it is doing the first steps to enter in the field of biosimilars and also marketing biomaterials from horse bone.
|
|
|
|
|
|
|
|
Plant Bioproducts is developing a new line of enzymatic products in genetically modified plants. Currently they are focusing on the production of cellulases and their use in the simultaneous saccharification and fermentation of lignocellulosic biomass.
|
|
|
|
|
|
PBS (Protein Alternatives S.L.) is a recently founded biotechnology company, with a strong expertise in those technologies required for the production of recombinant proteins and antibodies. The goal of the company is to investigate and generate novel recombinant proteins and antibodies in order to supply new tools for research and for the diagnosis and/or therapy of pathologies like cancer, diabetes or cardiovascular diseases. Additionally, we offer services of protein expression and purification, antibodies generation.
|
|
|
|
Sabiobbi is a company dedicated to the marketing, distribution and research of products and services related to Human Health. Its aim is to achieve a personalized medicine using treatments based on biotechnologic diagnosis.
Sabiobbi offers genetic tests through DNA microarrays (biochips) that allow:
- To prevent risks associated with age-related diseases (“AgingChip”);
- To measure our physical and metabolic capacity, assessing the potential of response to physical training (“SportChip”);
- To guide on the criteria to be followed in connection with our habits and way of life (“QualityChip”).
|
|
|
|
|
|
Secugen comes out as a company devoted to DNA analysis from different organisms and aims to develop an important part of its business in the characterization of genetic variability and its application to molecular diagnostics. In this respect, Secugen S.L. has a dual objective: on one hand, to provide support to professionals in the genetic and molecular diagnostics fields; on the other, to perform R&D activities on new technologies and applications in molecular diagnostics.
|
|
|
|
Sensia technology is based on state of the art optical micro-nano devices. The company is currently focusing on label-free and real time detection of molecular interactions applied to environmental monitoring and food quality. |
|
|
|
|
|
Sector: Fine Chemicals.
Objectives: Be the world-leading company in the production of ingredients by supercritical CO2 technologies for the pharmaceutical, cosmetic, nutritional, food and beverage industries.
Products:
- EPA (Eicosapentaenoic Acid) until 95%
- DHA (Docosahexaenoic Acid) until 85%
- SDA (Stearidonic Acid) until 50%
- Omega-3 PUFAS until 95%
- Lycopene until 50%
- Terpeneless Citrus Oils in the desired folding
- Sesquiterpeneless Citrus Oils in the desired folding
- Terpenes
- Sesquiterpenes
- Magnetic Nanoparticles
|
|
|
|
SUANFARMA has spun out the biotechnology division in order to set it up as a Venture Capital company. An investment fund is being developed to invest in approximately 10 biotech start-ups. SUANFARMA provides a wide range of services to the portfolio of biotech companies under our supervision: management, international marketing, business development, industrail production and fund-raising.
|
|
|
|
|
|
Vivotecnia offers a specialized service in toxicological, pharmacological and biomedical research. Our company provides the first Animal contract research service in Madrid that complies with Good Laboratory Practice (GLP) standards. |
|
|
|
ZF Biolabs is focused on providing new tools for drug discovery and toxicity assesment based on the use of the Zebrafish. ZF Biolabs has developed its own technology for zebrafish embryo production and has also launched a new teratogenic assay using zebrafish. |
|
|
|
